September 1, 2017 — Biotronik recently announced data from the BIOFLOW-V randomized trial comparing Orsiro and Xience ...
August 21, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of ...
July 21, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX ...
July 13, 2017 — Experts in heart failure management gathered in June to discuss varying scientific evidence in their ...
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve ...
May 23, 2017 – Results now published in the European Heart Journal show Biotronik Home Monitoring reduces the risk of ...
May 11, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval of the company's MultiPole Pacing ...
May 10, 2017 — Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved ...
May 9, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and the launch of Sentus ProMRI, the ...
April 28, 2017 — Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world setting ...